DV
Dividend Vision

PLRX — Pliant Therapeutics Inc

Pliant Therapeutics Inc (PLRX)

Total return is -95.0% over the past 6.2 years, 266.2 points behind SPY at 171.2%. Its deepest 1-year drawdown was 44.9%.

PLRX is a single-stock equity holding in Pliant Therapeutics Inc, a biopharmaceutical company, rather than a diversified ETF. The security does not currently distribute dividends, resulting in no yield profile or regular income distributions. This holding appeals primarily to growth-oriented investors seeking exposure to the biotechnology sector, as returns depend on capital appreciation rather than dividend income.

PLRX key facts

Asset type
Stock
Asset class
Equity
Inception date
06/03/2020
Last close
$1.07
Market cap
$67,493,072
Average volume
235026.0
Beta
1.217
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.88